Seeing is believing: the impact of structural genomics on antimicrobial drug discovery

Nature Reviews. Microbiology
Molly B Schmid

Abstract

Over the past decade, the availability of complete microbial genome sequences has led to changes in the strategies that are used to search for novel anti-infectives. However, despite the identification of many new potential drug targets, novel antimicrobial agents have been slow to emerge from these efforts. In part, this reflects the long discovery and development times that are needed to bring new drugs to market and the bottlenecks at the stages of identifying good lead compounds and optimizing these leads into drug candidates. Structural genomics will hopefully provide opportunities to overcome these bottlenecks and populate the antimicrobial pipeline.

References

Jul 28, 1995·Science·R D FleischmannJ M Merrick
Nov 8, 1996·Science·H R OnishiC R Raetz
Jul 17, 1998·Current Opinion in Chemical Biology·G S SittampalamW P Janzen
Aug 6, 1998·Current Opinion in Chemical Biology·L SilvermanJ R Broach
Mar 26, 1999·Bioorganic & Medicinal Chemistry Letters·M H ChenC R Raetz
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Oct 3, 2000·Nature·B T WimberlyV Ramakrishnan
Oct 4, 2000·Nature Structural Biology·D ChristendatC H Arrowsmith
Apr 3, 2001·Science·M M YusupovH F Noller
Sep 22, 2001·Protein Science : a Publication of the Protein Society·X QiuR L Jarvest
Jan 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Brian J AkerleyJohn J Mekalanos
Apr 16, 2002·Molecular Microbiology·R Allyn ForsythJudith W Zyskind
May 1, 2002·Nature Biotechnology·Joseph A DeVitoDavid L Pompliano
Jun 28, 2002·Journal of Medicinal Chemistry·Toni KlineShuguang Zhu
Aug 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Scott A LesleyRaymond C Stevens
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·David J PayneWilliam F Huffman
Oct 22, 2002·Nature Structural Biology·Daniel Lim, Natalie C J Strynadka
Nov 19, 2002·International Journal for Parasitology·Azin Nezami, Ernesto Freire
Jan 10, 2003·Nucleic Acids Research·John WestbrookHelen M Berman
Feb 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jingtong HouSung-Hou Kim
Mar 15, 2003·Science·M GersteinG T Montelione
Mar 19, 2003·Accounts of Chemical Research·Renaud VincentelliChristian Cambillau
Apr 30, 2003·Journal of Structural Biology·Celia W Goulding, L Jeanne Perry
Apr 30, 2003·Journal of Structural Biology·David HosfieldRaymond C Stevens
May 31, 2003·Nature Reviews. Drug Discovery·Bernard Fermini, Anthony A Fossa
Jun 21, 2003·Current Drug Targets·J C Wilson, M von Itzstein
Jun 24, 2003·Proceedings of the National Academy of Sciences of the United States of America·Douglas A WhittingtonDavid W Christianson
Jun 27, 2003·Current Opinion in Chemical Biology·Andrew Sharff, Harren Jhoti
Jul 2, 2003·Nature Structural Biology·Brian E CogginsPei Zhou
Jul 11, 2003·Bioorganic & Medicinal Chemistry Letters·Justin BowerStephen Roughley
Sep 23, 2003·Biophysical Chemistry·Celia W GouldingDavid Eisenberg
Oct 28, 2003·Proteins·Ceslovas VenclovasJohn Moult
Nov 6, 2003·Journal of Biomolecular Screening·Philip J HajdukStephen W Fesik
Nov 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michael A JacobsColin Manoil
Dec 3, 2003·Journal of Structural and Functional Genomics·Naomi E Chayen
Dec 3, 2003·Journal of Structural and Functional Genomics·Chantal AbergelJean-Michel Claverie
Dec 17, 2003·Current Opinion in Structural Biology·Clare V Smith, James C Sacchettini

❮ Previous
Next ❯

Citations

Apr 14, 2005·International Journal for Parasitology·E A Worthey, P J Myler
Jul 4, 2009·ACS Chemical Biology·Terence I MoyFrederick M Ausubel
Jan 18, 2008·BMC Structural Biology·David PiedraXavier de la Cruz
Jan 20, 2006·Genome Biology·Matthew B Avison
Mar 7, 2006·Genome Biology·Paul Kellam
Jun 2, 2009·Current Opinion in Microbiology·Thomas R Ioerger, James C Sacchettini
Apr 26, 2006·Drug Discovery Today·John J Barker
Jan 3, 2006·Biochemical Pharmacology·Scott D Mills
Jan 18, 2006·Biochemical Pharmacology·Michael J Pucci
Feb 7, 2006·Biochemical Pharmacology·Molly B Schmid
Aug 1, 2007·Expert Opinion on Drug Discovery·Tod P HollerLakshmi Narasimhan
May 19, 2012·International Journal of Molecular Sciences·Shaopeng WeiZhiqin Ji
Jun 17, 2010·Nature Reviews. Microbiology·Katie J SimmonsColin W G Fishwick
Jan 21, 2006·Journal of Evaluation in Clinical Practice·Lyndal J TrevenaPatrina Caldwell
Feb 23, 2012·Journal of Physics. Condensed Matter : an Institute of Physics Journal·Matteo CeccarelliPaolo Ruggerone
Jan 1, 2006·Current Protocols in Pharmacology·Michael J Pucci
Jan 27, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nolan Neville, Zongchao Jia
Jul 4, 2007·The Journal of Antimicrobial Chemotherapy·Hee Soo ParkJin-Hwan Kwak
Nov 5, 2014·Journal of Proteome Research·Ramy H MaltyMohan Babu
Jun 1, 2005·Journal of Chemical Information and Modeling·Martin J BayleyPeter J Artymiuk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.